GlassScriptPhysician profile
Alan M Verm
NPI 1558320382
$1,726.50
in general payments reported to CMS, 2019-2025
22 companies · $609 in 2025
The $609 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $205 · 2021: $56.96 · 2022: $42.20 · 2023: $216 · 2024: $386 · 2025: $609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,210.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $664.11 | 2019-2025 | Clareon, Simbrinza, Clareon Panoptix Pro |
| New World Medical,INC. | $188.60 | 2025 | Clearpath, Via360, Streamline |
| Tarsus Pharmaceuticals, INC. | $186.91 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $128.01 | 2019-2021 | |
| Ivantis, INC | $115.73 | 2020 | |
| Sandoz INC. | $55.72 | 2024 | Cimerli |
| Abbvie INC. | $50.46 | 2024 | |
| Omeros Corporation | $49.66 | 2019 | |
| Kala Pharmaceuticals, INC. | $38.62 | 2020 | |
| Carl Zeiss Meditec USA, INC. | $26.66 | 2025 | Iolmaster 700 |
| Biotissue Holdings INC. | $24.86 | 2023 | |
| Glaukos Corporation | $23.59 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Apellis Pharmaceuticals, INC. | $21.24 | 2024 | Syfovre |
| Bausch & Lomb Americas INC. | $19.85 | 2024 | Vyzulta, Miebo |
| Allergan, INC. | $19.51 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $18.95 | 2021 | |
| Biogen, INC. | $18.73 | 2023 | |
| Eyepoint US, INC. | $16.48 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $15.22 | 2024 | Tecnis Iol |
| Ani Pharmaceuticals, INC. | $15.14 | 2023 | Purified Cortrophin Gel |
| Genentech USA, INC. | $14.65 | 2020 | |
| Oyster Point Pharma, INC. | $13.80 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Verm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.